The Children’s Tumor Foundation (CTF), a global leader in funding and driving research into all forms of the genetic condition NF, is pleased to announce the appointment of Kimberly Snipes as the newest member of its Board of Directors. Kimberly brings a formidable array of expertise to her role on the CTF Board, with a rich background in technology leadership and operations management. Her industry acumen and insightful perspectives will be instrumental in steering the Foundation’s innovation endeavors, expediting the development of treatments for NF patients.
Kimberly is currently an Executive Vice President at Key Bank in Cleveland, Ohio, responsible for the end-to-end transformation of the commercial servicing and onboarding experiences across business banking, commercial, and institutional clients in 26 markets. The mission of Kimberly’s organization is to create differentiated client experiences that can scale with growth and optimally leverage both digital platforms and field personnel to support Key’s clients.
Prior to her current role, Kimberly served in technology executive and CIO roles for multiple financial institutions including Bank of America, Capital One, USAA, and Key Bank. As CIO, she established and successfully delivered on a transformative technology roadmap aligned with the business priorities, performed strategic and operational planning and execution, and managed to best-in-class cost efficiency and system availability standards.
A fervent advocate for women in technology and broader diversity, equity, and inclusion in the workplace, Kimberly actively contributes to Key’s Diversity, Equity, and Inclusion committee and has served in leadership roles on various internal advocacy groups. Additionally, Kimberly lends her expertise to the Ashland University women’s leadership advisory board, where she helps craft impactful curricula to elevate women’s professional development and career progress.
Kimberly and her husband Bryan are the proud parents of Madison, who is an NF fighter and inspiration. Madison was diagnosed with NF1 at the age of four, and Kimberly and Bryan encourage her to defy her NF1 challenges and embrace new experiences in pursuit of her passions.
In her new role on the CTF Board, Kimberly is looking forward to leveraging her expertise in technology, operations, and overall business leadership to support the CTF vision and approach to research and medical advancements, making a tangible impact on the NF community.
Please join us in extending a warm welcome to Kimberly Snipes to the CTF Board!
